Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Mindray Medical Receives $3.5 Billion Go-Private Offer

publication date: Jun 4, 2015
Mindray Medical, the Shenzhen medical device maker, received a going-private offer from its three top executives of $30 per ADS, a modest 10% over yesterday's closing price. The offer values Mindray at $3.5 billion. In its Q1 earnings report, Mindray warned that its net income for 2015 would fall by a mid-teens percentage. Brokerage houses responded by lowering their ratings on the company, some to a sell and others to a strong sell. Previous to the Q1 earnings report, Mindray was trading above $30 per ADS. More details....

Stock Symbol: (NYSE: MR)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital